Get the Stockscreener App
8.15
2.64%
-0.18
Novavax Inc Stock (NVAX) Latest News
Novavax Q4 Loss Narrower Than Expected, Sales Beat Estimates - MSN
Stock Market Insights: Snap And Novavax Trends - Evrim Ağacı
Novavax sees royalties, reduced expenses on COVID vaccines from Sanofi partnership - MSN
Novavax, Inc. (NASDAQ:NVAX) Shares Could Be 45% Below Their Intrinsic Value Estimate - Yahoo Finance
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Novavax Q4 Earnings Review: Long-Term Downsizing Plan Suggests Sell Rating (NASDAQ:NVAX) - Seeking Alpha
Novavax, Inc. (NASDAQ:NVAX) Q4 2024 Earnings Call Transcript - Insider Monkey
1 Biotech Stock to Buy in 2025, and 1 to Avoid - MSN
Decoding Novavax Inc (NVAX): A Strategic SWOT Insight - GuruFocus.com
Novavax Inc (NVAX) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial ... - Yahoo Finance
Novavax Inc (NVAX) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial ... By GuruFocus - Investing.com Canada
Novavax: Q4 Earnings Snapshot - Huron Daily Tribune
Novavax Reports 2024 Earnings and Strategic Shift - TipRanks
Novavax Lands Wall Street 'Buy' Rating After Q4 Results, Retail Bulls Eye More Upside On Sanofi Partnership - MSN
Novavax initiated with a Buy at BTIG - TipRanks
Novavax Earnings Call: Strategic Moves and Challenges - TipRanks
Novavax Looks To Right Its Ship Amid Revenue Slump - Citeline News & Insights
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Novavax, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Novavax Stock: Narrowing Losses Drive Market Confidence - sharewise
Novavax to Participate in Upcoming March Investor Conferences - PR Newswire
Novavax execs lay out 2025 game plan, talk ‘defining moment’ for business - The Business Journals
Novavax rising after reporting narrower Q4 loss, revenue beat - Yahoo Finance
Novavax : manages to reduce losses in 2024 -February 27, 2025 at 11:06 am EST - Marketscreener.com
Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value - Yahoo Finance
Novavax's quarterly loss shrinks as it ramps down spending on COVID vaccines - MSN
Novavax Inc reports results for the quarter ended December 31Earnings Summary - TradingView
NVAX Earnings: Novavax Stock Jumps Despite Mixed Q4 Results - Markets Insider
Earnings call transcript: Novavax Q4 2024 sees revenue drop, stock rises - Investing.com
Novavax reports large quarterly revenue declines, rethinks its strategic direction - Yahoo Finance
Novavax’s quarterly loss shrinks as it ramps down spending on COVID vaccines By Reuters - Investing.com Canada
Novavax posts Q4 revenue beat despite 80% drop in product sales - MSN
Novavax Q4 Net Loss Narrows, Revenue Falls -February 27, 2025 at 09:12 am EST - Marketscreener.com
Novavax (NVAX) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Novavax's quarterly loss shrinks as it ramps down spending on COVID vaccines -February 27, 2025 at 09:08 am EST - Marketscreener.com
Novavax stock on watch after Q4 results (NVAX:NASDAQ) - Seeking Alpha
Novavax Sees Reduced Q4 Losses and Strategic Shifts AheadNews and Statistics - IndexBox, Inc.
Earnings Flash (NVAX) NOVAVAX INC. Posts Q4 Revenue $88.3M, vs. FactSet Est of $84.4M - Marketscreener.com
Novavax: Q4 Earnings Snapshot -February 27, 2025 at 08:19 am EST - Marketscreener.com
Novavax Looks To Sanofi Partnership After Narrowing Quarterly Losses - Finimize
Novavax Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights - TradingView
Novavax earnings beat by $0.09, revenue fell short of estimates - Investing.com UK
Novavax's quarterly loss shrinks as it ramps down spending on COVID vaccines -February 27, 2025 at 08:06 am EST - Marketscreener.com
Novavax Stock Is Rising. Investors Cheer Revenue Beat, Vaccine Shift. - Barron's
NOVAVAX INC SEC 10-K Report - TradingView
Novavax Retail Traders Stay Bullish Ahead Of Q4 Print Even As RFK Jr's HHS Leadership Causes Ripples - MSN
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Novavax Projects Profitability in 2025 Amid Vaccine Challenges - TradingView
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement - ACCESS Newswire
Breakeven Is Near for Novavax, Inc. (NASDAQ:NVAX) - Simply Wall St
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
What's in Store for These 5 Biotech Stocks This Earnings Season? - Nasdaq
Novavax to Report Q4 Earnings: Here's What You Can Expect - MSN
(NVAX) Technical Pivots with Risk Controls - Stock Traders Daily
Novavax, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsNVAX - ACCESS Newswire
Novavax call volume above normal and directionally bullish - MSN
Chinese researchers find bat virus enters human cells via same pathway as COVID - Reuters
Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China - Investopedia
3.91%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):